CB1 receptor antagonists for the treatment of nicotine addiction.
about
Smoking tobacco along with marijuana increases symptoms of cannabis dependenceEndocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibitionSymbiotic relationship of pharmacogenetics and drugs of abuse.Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seekingA research agenda for assessing the potential contribution of genomic medicine to tobacco control.Treatment of nicotine addiction: present therapeutic options and pipeline developments.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceTreatment models for targeting tobacco use during treatment for cannabis use disorder: case series.Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerolDrug addiction.Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?Extinction learning of rewards in the rat: is there a role for CB1 receptors?Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways.Nicotine addiction and comorbidity with alcohol abuse and mental illness.Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use.Neuropharmacology and potential efficacy of new treatments for tobacco dependence.Therapeutic advances in the treatment of nicotine addiction: present and future.Current and emerging pharmacotherapies for treating tobacco dependence.Dopamine D3 receptor ligands for the treatment of tobacco dependence.An uncontrolled trial of cytisine (Tabex) for smoking cessationBlockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabantTolerance to Ethanol or Nicotine Results in Increased Ethanol Self-Administration and Long-Term Depression in the Dorsolateral StriatumMutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studiesA role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions[Future medications for tobacco and cannabis dependence].The endogenous cannabinoid system modulates nicotine reward and dependence.Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach.Neuroinflammation as a possible link between cannabinoids and addiction.The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in ratsCross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trialCannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms.Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations
P2860
Q24650310-516D8507-B5F9-4509-A8D3-732DD1F3EFCEQ27311588-2B8AF484-DB14-4B56-9B63-48E30FFE1EBDQ28476270-3D24B181-F537-4F93-B48C-0E997D52D6ECQ28480387-F76ED112-09D1-4508-8B20-3FDD57380BEFQ30230101-4A95A9B6-9927-470E-B67B-D181CE8B2898Q30398847-28DA1EE0-F1B2-4AE7-B189-032C70DDDBA7Q33703839-40B62F92-A86C-49D8-B216-100BFB29504EQ33791704-80F6536D-D5C5-4033-94B6-2D69A158D796Q34254854-D830EFE3-DAC5-4843-A730-D35EAA707F94Q34575484-1E0EE8F6-1F95-440E-BAF9-BD06465A68DEQ34967151-095205AF-ACDC-4B97-90C4-CB3C77A74C0FQ35179535-42BDA613-39E6-4CE3-A203-060181DFC72FQ36174329-727180D0-313E-4C7E-98BA-B653F62BFA8CQ36298360-934B46B3-949F-41AF-96ED-290079362FA1Q36352347-15752A5F-7FF6-4203-A357-37FE48B19C57Q36376434-37E7D16A-A52D-47CB-A53A-20D6FBC62E6DQ36443676-952B4668-8D30-43A9-901E-37EF54329E3AQ36580581-8734F29E-4C6C-47BA-BF30-C261BC3B2211Q36677397-CD31B45C-DE45-46BA-AD8F-5F3768FD6DA8Q36928196-924B33DD-2815-4603-B197-ACA120FA7517Q36978979-7BE2CFD0-B156-483F-8A53-482B8B848B68Q37150613-CB661180-F150-43F8-8CF3-90176AFD9E0BQ37154000-E9AD8AB5-54EC-4FD0-8EC0-428381E66DB9Q37164812-A2241441-B7A9-4A39-9991-4B886A4E776BQ37208086-77DF4F8A-8A01-43B1-9A56-01A0263B6EEFQ37347842-08F0D8DB-3858-4EA5-BB84-E7693615E4BBQ37353755-30D8B285-C543-486A-A42E-4A1746CBE27EQ37414652-FBF0D90B-33A1-479B-8A53-58137C6E78C6Q37728629-47D24A73-3DFE-410A-80CD-639CE95477DAQ38278954-57C9A767-4F60-4431-A0D8-4E0F02642B51Q40446321-15335D4D-75BF-414A-9BC1-88399BDA55BAQ41967071-4B40CF6E-231D-4067-930C-98ECB96EEC04Q42060895-9CE83545-5E64-4E44-B4FC-F997B6144D73Q42608588-4890BA6D-8D72-4DD5-B535-14B915DF9747Q42676081-64544AB1-E710-4DE7-94F0-3C638083FBAAQ45288843-360304BE-0A64-4325-A7B3-0E832F10CF18Q46111417-ADD7CD60-B56E-4003-8D1B-83540CAD7033Q48139928-81A718E7-CBB9-434C-8004-53FBCC7E0F9FQ50248388-FF3EDF34-DA2C-437E-99E2-FC244F4571F7Q58743634-D459E92F-6B28-4DAB-91F5-EE7D76F1B2E0
P2860
CB1 receptor antagonists for the treatment of nicotine addiction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CB1 receptor antagonists for the treatment of nicotine addiction.
@ast
CB1 receptor antagonists for the treatment of nicotine addiction.
@en
type
label
CB1 receptor antagonists for the treatment of nicotine addiction.
@ast
CB1 receptor antagonists for the treatment of nicotine addiction.
@en
prefLabel
CB1 receptor antagonists for the treatment of nicotine addiction.
@ast
CB1 receptor antagonists for the treatment of nicotine addiction.
@en
P2093
P1476
CB1 receptor antagonists for the treatment of nicotine addiction.
@en
P2093
Caroline Cohen
Ercem Kodas
Guy Griebel
P304
P356
10.1016/J.PBB.2005.01.024
P407
P577
2005-06-01T00:00:00Z